Mikobakterilerin Hücre Yapısı
Referanslar
World Health Organization. Global Tuberculosis Report 2025. Geneva: World Health Organization; 2025.
mondiale de la Santé O, Organization WH. Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible–Time to act!= Situation de la lèpre (maladie de Hansen) dans le monde, 2023: L’élimination de la lèpre est possible–Il est temps d’agir! Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire. 2024;99(37):501-21.
Alderwick LJ, Harrison J, Lloyd GS, Birch HL. The mycobacterial cell wall—peptidoglycan and arabinogalactan. Cold Spring Harbor perspectives in medicine. 2015;5(8):a021113.
Daffé M, Marrakchi H. Unraveling the structure of the mycobacterial envelope. Microbiology spectrum. 2019;7(4):10.1128/microbiolspec. gpp3-0027-2018.
Abrahams KA, Besra GS. Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target. Parasitology. 2018;145(2):116-33.
Marrakchi H, Lanéelle M-A, Daffé M. Mycolic acids: structures, biosynthesis, and beyond. Chemistry & biology. 2014;21(1):67-85.
Jackson M. The mycobacterial cell envelope—lipids. Cold Spring Harbor perspectives in medicine. 2014;4(10):a021105.
Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. Journal of experimental medicine. 2009;206(13):2879-88.
Augenstreich J, Haanappel E, Ferré G, Czaplicki G, Jolibois F, Destainville N, et al. The conical shape of DIM lipids promotes Mycobacterium tuberculosis infection of macrophages. Proceedings of the National Academy of Sciences. 2019;116(51):25649-58.
Cambier C, Takaki KK, Larson RP, Hernandez RE, Tobin DM, Urdahl KB, et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature. 2014;505(7482):218-22.
Vilchèze C, Kremer L. Acid-fast positive and acid-fast negative Mycobacterium tuberculosis: the Koch paradox. Microbiology spectrum. 2017;5(2):10.1128/microbiolspec. tbtb2-0003-2015.
Takayama K, Wang C, Besra GS. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clinical microbiology reviews. 2005;18(1):81-101.
Vilchèze C, Jacobs J, William R. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol. 2007;61(1):35-50.
Brown-Elliott BA, Wallace Jr RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clinical microbiology reviews. 2002;15(4):716-46.
Bercovier H, Kafri O, Sela S. Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome. Biochemical and biophysical research communications. 1986;136(3):1136-41.
Gröschel MI, Sayes F, Simeone R, Majlessi L, Brosch R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nature Reviews Microbiology. 2016;14(11):677-91.
Procop GW. Laboratory diagnosis and susceptibility testing for Mycobacterium tuberculosis. Tuberculosis and Nontuberculous Mycobacterial Infections. 2017:45-58.
Scollard DM, Adams L, Gillis T, Krahenbuhl J, Truman R, Williams D. The continuing challenges of leprosy. Clinical microbiology reviews. 2006;19(2):338-81.
Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. The Journal of experimental medicine. 2003;198(5):705-13.
Rustad TR, Sherrid AM, Minch KJ, Sherman DR. Hypoxia: a window into Mycobacterium tuberculosis latency. Cellular microbiology. 2009;11(8):1151-9.
Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Molecular microbiology. 2003;48(3):833-43.
Kumar A, Toledo JC, Patel RP, Lancaster Jr JR, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proceedings of the National Academy of Sciences. 2007;104(28):11568-73.
Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. Journal of bacteriology. 2010;192(6):1662-70.
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α–neutralizing agent. New England Journal of Medicine. 2001;345(15):1098-104.
Zheng H, Colvin CJ, Johnson BK, Kirchhoff PD, Wilson M, Jorgensen-Muga K, et al. Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence. Nature chemical biology. 2017;13(2):218-25